Kestra Medical Technologies, Ltd. SEC filings KMTS

Kestra Medical Technologies, Ltd. has 187 filings in SEC EDGAR's recent list, going back to Aug 25, 2021. Its latest annual report, Form ARS, was filed on Jul 28, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 14, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (results of operations). The company's fiscal year ends on April 30.

Kestra Medical Technologies, Ltd. SEC filings
Form Description Filed Period
10-Q Quarterly report Sep 14, 2026 Jul 31, 2026
8-K Current report
Results of operations
Sep 14, 2026 Sep 14, 2026
8-K Current report
Shareholder vote results
Sep 10, 2026 Sep 9, 2026
ARS Annual report to shareholders Jul 28, 2026 Apr 30, 2026
DEFA14A Additional proxy material Jul 28, 2026 —
DEF 14A Proxy statement Jul 28, 2026 Sep 9, 2026
10-K Annual report Jul 14, 2026 Apr 30, 2026
8-K Current report
Material agreement, Agreement ended, Results of operations, New debt
Jul 14, 2026 Jul 10, 2026
S-3ASR Automatic shelf registration Apr 1, 2026 —
S-8 Employee stock plan registration Mar 18, 2026 —
10-Q Quarterly report Mar 17, 2026 Jan 31, 2026
8-K Current report
Results of operations
Mar 17, 2026 Mar 17, 2026
10-Q Quarterly report Dec 11, 2025 Oct 31, 2025
8-K Current report
Results of operations
Dec 11, 2025 Dec 11, 2025
8-K Current report
Material agreement
Dec 4, 2025 Dec 2, 2025
424B4 Prospectus Dec 3, 2025 —
EFFECT Filing Dec 2, 2025 —
S-1MEF Filing Dec 2, 2025 —
CORRESP Letter to the SEC Dec 1, 2025 —
CORRESP Letter to the SEC Dec 1, 2025 —
S-1 Registration statement Dec 1, 2025 —
8-K Current report
Results of operations
Dec 1, 2025 Dec 1, 2025
8-K Current report
Regulation FD disclosure
Nov 10, 2025 Nov 10, 2025
DRS Filing Oct 29, 2025 —
10-Q Quarterly report Sep 12, 2025 Jul 31, 2025
8-K Current report
Results of operations
Sep 11, 2025 Sep 11, 2025
8-K Current report
Shareholder vote results
Sep 4, 2025 Sep 3, 2025
ARS Annual report to shareholders Jul 22, 2025 Apr 30, 2025
DEFA14A Additional proxy material Jul 22, 2025 —
DEF 14A Proxy statement Jul 22, 2025 Sep 3, 2025
10-K Annual report Jul 17, 2025 Apr 30, 2025
8-K Current report
Results of operations
Jul 15, 2025 Jul 15, 2025
8-K Current report
Officer or director change
Jun 6, 2025 Jun 4, 2025
10-Q Quarterly report Apr 17, 2025 Jan 31, 2025
8-K Current report
Results of operations
Apr 14, 2025 Apr 14, 2025
S-8 Employee stock plan registration Mar 7, 2025 —
8-K Current report
Material agreement, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
Mar 7, 2025 Mar 5, 2025
424B4 Prospectus Mar 6, 2025 —
CERT Filing Mar 6, 2025 —
8-A12B Filing Mar 6, 2025 —
EFFECT Filing Mar 5, 2025 —
S-1MEF Filing Mar 5, 2025 —
CORRESP Letter to the SEC Mar 3, 2025 —
CORRESP Letter to the SEC Mar 3, 2025 —
S-1/A Amended registration statement Mar 3, 2025 —
CORRESP Letter to the SEC Feb 27, 2025 —
S-1/A Amended registration statement Feb 26, 2025 —
S-1 Registration statement Feb 10, 2025 —
DRSLTR Filing Feb 4, 2025 —
DRS/A Filing Feb 4, 2025 —
UPLOAD Letter from the SEC Jan 29, 2025 —
DRSLTR Filing Jan 17, 2025 —
DRS/A Filing Jan 17, 2025 —
UPLOAD Letter from the SEC Jan 7, 2025 —
DRSLTR Filing Dec 11, 2024 —
DRS/A Filing Dec 11, 2024 —
UPLOAD Letter from the SEC Dec 8, 2021 —
DRSLTR Filing Nov 23, 2021 —
DRS/A Filing Nov 23, 2021 —
UPLOAD Letter from the SEC Sep 29, 2021 —
DRS Filing Aug 25, 2021 —

Showing 61 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
KMTS (Nasdaq)
Fiscal year ends
April 30
Incorporated in
Bermuda
Headquarters
Kirkland, WA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1877184

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.